Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) Short Interest Down 32.4% in June

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) saw a large decline in short interest during the month of June. As of June 30th, there was short interest totalling 422,200 shares, a decline of 32.4% from the May 30th total of 624,100 shares. Based on an average daily trading volume, of 178,100 shares, the short-interest ratio is currently 2.4 days. Currently, 0.7% of the company’s stock are short sold.

A number of analysts have issued reports on the company. Zacks Investment Research downgraded HEXO from a “hold” rating to a “sell” rating in a report on Wednesday, May 15th. ValuEngine downgraded Zosano Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Finally, BidaskClub downgraded Vertex Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Tuesday.

Institutional investors and hedge funds have recently bought and sold shares of the company. Stifel Financial Corp acquired a new position in Calumet Specialty Products Partners, L.P in the 4th quarter valued at about $34,000. Janney Montgomery Scott LLC purchased a new stake in Calumet Specialty Products Partners, L.P in the 1st quarter valued at approximately $37,000. Mercer Global Advisors Inc. ADV purchased a new stake in Calumet Specialty Products Partners, L.P in the 1st quarter valued at approximately $47,000. Independent Advisor Alliance purchased a new stake in Calumet Specialty Products Partners, L.P in the 1st quarter valued at approximately $75,000. Finally, Fiera Capital Corp purchased a new stake in Calumet Specialty Products Partners, L.P in the 1st quarter valued at approximately $78,000. Institutional investors and hedge funds own 14.56% of the company’s stock.

Shares of CLMT traded up $0.24 during midday trading on Friday, reaching $4.64. 445,849 shares of the stock were exchanged, compared to its average volume of 109,999. The firm has a 50-day simple moving average of $4.29. The company has a debt-to-equity ratio of 22.97, a current ratio of 1.33 and a quick ratio of 0.82. Calumet Specialty Products Partners, L.P has a twelve month low of $1.99 and a twelve month high of $7.95. The stock has a market cap of $340.86 million, a P/E ratio of 15.47 and a beta of 1.76.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last posted its earnings results on Friday, May 10th. The oil and gas company reported ($0.05) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.35) by $0.30. Calumet Specialty Products Partners, L.P had a positive return on equity of 73.33% and a negative net margin of 0.93%. The business had revenue of $851.30 million for the quarter, compared to analysts’ expectations of $658.18 million. As a group, equities research analysts expect that Calumet Specialty Products Partners, L.P will post 0.38 earnings per share for the current year.

Calumet Specialty Products Partners, L.P Company Profile

Calumet Specialty Products Partners, L.P. produces and sells specialty hydrocarbon products in North America and internationally. It operates in two segments, Specialty Products and Fuel Products. The Specialty Products segment offers various lubricating oils, white mineral oils, solvents, petrolatums, waxes, synthetic lubricants, and other products which are used primarily as raw material components for basic automotive, industrial, and consumer goods.

Recommended Story: Differences Between Momentum Investing and Long Term Investing

Receive News & Ratings for Calumet Specialty Products Partners L.P Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners L.P and related companies with MarketBeat.com's FREE daily email newsletter.